Tiapride

Chemical formula: C₁₅H₂₄N₂O₄S  Molecular mass: 328.427 g/mol  PubChem compound: 5467

Pharmacodynamic properties

Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine). These properties have been confirmed in neurochemical and behavioural studies in which antidopaminergic properties have been demonstrated in the absence of sedation, catalepsy and cognitive impairment.

Pharmacokinetic properties

Tiapride is rapidly absorbed. Maximal concentration of the active substance are reached as early as within one hour.

The absolute bioavailability of the tablets is 80%.

Tiapride is mostly eliminated in the first 24 hour urine. Tiapride is mainly eliminated as the parent compound, although two metabolites have been identified. These are the N-oxide and the N-monodesethyl derivatives of the active substance. The elimination half-life is about 3 hours.

Preclinical safety data

An increased incidence of breast tumours was observed in rats. This was probably due to hyperprolactinaemia as a consequence of the pharmacological action of the substance. This is probably a species-specific effect and does not constitute any particular risk to humans in therapeutic use. Other abnormalities seen in experimental animals were associated with the known pharmacological action.

A tiapride-induced reduced fertility was observed in rats due to a suppression of the estrous cycle in females and a reduced libido in males. These effects are related to the pharmacological effect of tiapride on prolactin secretion. In studies on reproductive toxicity no signs of teratogenicity were observed, however, embryotoxic effects occurred. In a study on peri-postnatal toxicity toxic effects in the offspring were seen following high doses.

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.